Clopidogrel-induced acquired haemophilia A in a post-TAVR patient: a case report and literature review
Clopidogrel, one of the most commonly used medications in cardiology, is recognized as one of the leading drugs associated with acquired haemophilia A. In this case report, a review of the literature on ticagrelor and clopidogrel-induced acquired haemophilia A is also included, emphasizing the need for extreme vigilance in patients on antiplatelet therapy who present with unexplained bleeding.
Authors
- Rewa Kohli
- Yani Zhang (ORCID: https://orcid.org/0000-0003-3578-1436)
- Muhammad Adnan Zaman (ORCID: https://orcid.org/0009-0000-5354-9863)
- Amna Amir
- Zonghao Pan (ORCID: https://orcid.org/0000-0001-7570-2902)
Institutions
- MedStar Washington Hospital Center (US)
- Conemaugh Health System (US)
Publication Details
- Journal
- European Heart Journal - Case Reports
- Published
- 2025-09-20
- DOI
- https://doi.org/10.1093/ehjcr/ytaf459
- Citations
- 1
- Primary Topic
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.63